KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $373.1 million.

  • Incyte's Gains from Investment Securities fell 152.13% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.3 million, marking a year-over-year decrease of 40.63%. This contributed to the annual value of $373.1 million for FY2024, which is 1.36% down from last year.
  • Incyte's Gains from Investment Securities amounted to $373.1 million in FY2024, which was down 1.36% from $378.2 million recorded in FY2023.
  • Incyte's 5-year Gains from Investment Securities high stood at $378.2 million for FY2023, and its period low was $5.5 million during FY2020.
  • For the 3-year period, Incyte's Gains from Investment Securities averaged around $295.8 million, with its median value being $373.1 million (2024).
  • As far as peak fluctuations go, Incyte's Gains from Investment Securities plummeted by 44.19% in 2020, and later surged by 1,247.16% in 2022.
  • Incyte's Gains from Investment Securities (Yearly) stood at $5.5 million in 2020, then spiked by 83.37% to $10.1 million in 2021, then skyrocketed by 1,247.16% to $136.2 million in 2022, then skyrocketed by 177.60% to $378.2 million in 2023, then decreased by 1.36% to $373.1 million in 2024.